Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FMS Fresenius Medical Care AG & Co. KGaA	$27.49 -1.6%	$28.04	$17.93 ▼ $30.46	N/A	0.87	333,789 shs	205,854 shs
ISRG Intuitive Surgical	$527.30 -1.4%	$537.53	$413.82 ▼ $616.00	$191.65B	1.64	1.67 million shs	1.61 million shs
LGV Longview Acquisition Corp. II	$10.09	$10.09	$9.68 ▼ $10.15	N/A	N/A	N/A	N/A
TMO Thermo Fisher Scientific	$426.65 +1.9%	$409.13	$385.46 ▼ $627.88	$158.06B	0.77	1.98 million shs	2.62 million shs

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FMS Fresenius Medical Care AG & Co. KGaA	-0.64%	-2.31%	-2.07%	+24.00%	+42.04%
ISRG Intuitive Surgical	-1.66%	-1.60%	-4.02%	+16.84%	+20.50%
LGV Longview Acquisition Corp. II	0.00%	0.00%	0.00%	0.00%	0.00%
TMO Thermo Fisher Scientific	-2.22%	+3.19%	+4.17%	+0.29%	-22.47%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
FMS Fresenius Medical Care AG & Co. KGaA	2.9087 of 5 stars	1.0	1.0	2.5	0.0	2.6	0.0	5.0
ISRG Intuitive Surgical	4.7423 of 5 stars	3.4	3.0	0.0	4.0	3.5	2.5	1.9
LGV Longview Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TMO Thermo Fisher Scientific	4.9923 of 5 stars	4.4	3.0	2.5	4.1	3.4	2.5	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FMS Fresenius Medical Care AG & Co. KGaA	2.00	Hold	$27.80	1.13% Upside
ISRG Intuitive Surgical	2.70	Moderate Buy	$592.59	12.38% Upside
LGV Longview Acquisition Corp. II	0.00	N/A	N/A	N/A
TMO Thermo Fisher Scientific	2.80	Moderate Buy	$603.05	41.35% Upside

Current Analyst Ratings Breakdown

Latest LGV, FMS, ISRG, and TMO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/8/2025	TMO Thermo Fisher Scientific	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Neutral
7/8/2025	ISRG Intuitive Surgical	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	In-Line ➝ In-Line	$470.00 ➝ $550.00
7/8/2025	TMO Thermo Fisher Scientific	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$500.00 ➝ $480.00
6/24/2025	TMO Thermo Fisher Scientific	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$475.00 ➝ $450.00
6/9/2025	ISRG Intuitive Surgical	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Sell	$515.00 ➝ $440.00
6/5/2025	ISRG Intuitive Surgical	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
5/22/2025	ISRG Intuitive Surgical	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$590.00 ➝ $650.00
5/15/2025	FMS Fresenius Medical Care AG & Co. KGaA	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Underweight ➝ Underweight
5/12/2025	FMS Fresenius Medical Care AG & Co. KGaA	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$25.00 ➝ $30.00
4/29/2025	TMO Thermo Fisher Scientific	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$620.00 ➝ $470.00
4/25/2025	TMO Thermo Fisher Scientific	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$650.00 ➝ $605.00

(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FMS Fresenius Medical Care AG & Co. KGaA	$20.63B	N/A	$4.79 per share	5.74	$29.08 per share	N/A
ISRG Intuitive Surgical	$8.35B	22.63	$7.88 per share	66.94	$46.41 per share	11.36
LGV Longview Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A	N/A
TMO Thermo Fisher Scientific	$42.88B	3.76	$30.61 per share	13.94	$129.54 per share	3.29

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FMS Fresenius Medical Care AG & Co. KGaA	$582.08M	$1.12	24.54	14.32	0.66	3.18%	6.25%	2.88%	7/29/2025 (Estimated)
ISRG Intuitive Surgical	$2.32B	$6.82	77.32	69.11	5.67	28.41%	14.43%	12.81%	7/22/2025 (Estimated)
LGV Longview Acquisition Corp. II	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
TMO Thermo Fisher Scientific	$6.34B	$17.05	25.02	16.69	2.23	15.19%	17.15%	8.47%	7/23/2025 (Estimated)

Latest LGV, FMS, ISRG, and TMO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/29/2025	Q2 2025	FMS Fresenius Medical Care AG & Co. KGaA	$0.47	N/A	N/A	N/A	N/A	N/A
7/23/2025	Q2 2025	TMO Thermo Fisher Scientific	$5.22	N/A	N/A	N/A	$10.68 billion	N/A
7/22/2025	Q2 2025	ISRG Intuitive Surgical	$1.92	N/A	N/A	N/A	$2.35 billion	N/A
5/6/2025	Q1 2025	FMS Fresenius Medical Care AG & Co. KGaA	$0.43	$0.44	+$0.01	$0.26	$4.71 billion	$5.54 billion
4/23/2025	Q1 2025	TMO Thermo Fisher Scientific	$5.10	$5.15	+$0.05	$3.98	$10.23 billion	$10.36 billion
4/22/2025	Q1 2025	ISRG Intuitive Surgical	$1.71	$1.81	+$0.10	$1.92	$2.19 billion	$2.25 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
FMS Fresenius Medical Care AG & Co. KGaA	$0.57	2.07%	N/A	50.89%	N/A
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
LGV Longview Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
TMO Thermo Fisher Scientific	$1.72	0.40%	N/A	10.09%	8 Years

Latest LGV, FMS, ISRG, and TMO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/21/2025	TMO Thermo Fisher Scientific	quarterly	$0.43	0.43%	6/13/2025	6/13/2025	7/15/2025
5/9/2025	FMS Fresenius Medical Care AG & Co. KGaA	annual	$0.7871	1.9%	5/23/2025	5/23/2025	6/6/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FMS Fresenius Medical Care AG & Co. KGaA	0.40	1.46	1.08
ISRG Intuitive Surgical	N/A	4.98	3.97
LGV Longview Acquisition Corp. II	N/A	N/A	N/A
TMO Thermo Fisher Scientific	0.64	1.77	1.38

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FMS Fresenius Medical Care AG & Co. KGaA	8.37%
ISRG Intuitive Surgical	83.64%
LGV Longview Acquisition Corp. II	N/A
TMO Thermo Fisher Scientific	89.23%

Insider Ownership

Company	Insider Ownership
FMS Fresenius Medical Care AG & Co. KGaA	N/A
ISRG Intuitive Surgical	0.70%
LGV Longview Acquisition Corp. II	26.35%
TMO Thermo Fisher Scientific	0.33%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FMS Fresenius Medical Care AG & Co. KGaA	1,384	N/A	N/A	Optionable
ISRG Intuitive Surgical	15,638	358.42 million	355.91 million	Optionable
LGV Longview Acquisition Corp. II	3	N/A	N/A	Not Optionable
TMO Thermo Fisher Scientific	125,000	377.49 million	376.25 million	Optionable

LGV, FMS, ISRG, and TMO Headlines

Recent News About These Companies

TMO - Thermo Fisher Scientific Inc Financials - Morningstar

4 hours ago | morningstar.comM

Thermo Fisher Scientific Inc. (NYSE:TMO) Stake Lowered by DekaBank Deutsche Girozentrale

July 8 at 10:14 AM | marketbeat.com

Evercore ISI Lowers Thermo Fisher Scientific (NYSE:TMO) Price Target to $480.00

July 8 at 9:28 AM | marketbeat.com

M&T Bank Corp Sells 6,291 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

July 8 at 9:04 AM | marketbeat.com

Stratos Investment Management LLC Has $4.36 Million Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 8 at 8:37 AM | marketbeat.com

Thermo Fisher’s Oncomine Dx Express Test Receives FDA Approval

July 8 at 7:33 AM | msn.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Brown Advisory Inc.

July 8 at 7:29 AM | marketbeat.com

Ninety One UK Ltd Increases Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 8 at 6:52 AM | marketbeat.com

TD Private Client Wealth LLC Boosts Stake in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 8 at 6:08 AM | marketbeat.com

Envestnet Asset Management Inc. Lowers Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 8 at 5:58 AM | marketbeat.com

Thermo Fisher Scientific (TMO) Traded Down due to Concerns Over Spending Cuts

July 7 at 8:18 AM | insidermonkey.com

Financial Counselors Inc. Increases Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 7 at 7:05 AM | marketbeat.com

Capital Advisors Inc. OK Grows Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 7 at 6:21 AM | marketbeat.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Acquired by Roffman Miller Associates Inc. PA

July 7 at 6:10 AM | marketbeat.com

Thermo Fisher Scientific: Recovery In Sight, Attractively Valued

July 7 at 2:14 AM | seekingalpha.com

Thermo Fisher Scientific: Recovery In Sight, Attractively Valued

July 7 at 2:08 AM | seekingalpha.com

Chilton Capital Management LLC Raises Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 6 at 9:17 AM | marketbeat.com

Financiere des Professionnels Fonds d investissement inc. Trims Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 6 at 9:05 AM | marketbeat.com

Vickerman Investment Advisors Inc. Makes New $393,000 Investment in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 6 at 7:26 AM | marketbeat.com

Truist Financial Corp Sells 6,419 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

July 6 at 6:31 AM | marketbeat.com

Brookstone Capital Management Has $4.05 Million Stake in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 6 at 6:14 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?
By Leo Miller | June 19, 2025
View Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?

LGV, FMS, ISRG, and TMO Company Descriptions

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

$27.49 -0.46 (-1.65%)

Closing price 03:59 PM Eastern

Extended Trading

$27.51 +0.02 (+0.07%)

As of 04:32 PM Eastern

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Intuitive Surgical NASDAQ:ISRG

$527.30 -7.41 (-1.39%)

Closing price 04:00 PM Eastern

Extended Trading

$531.00 +3.70 (+0.70%)

As of 07:57 PM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Longview Acquisition Corp. II NYSE:LGV

Longview Acquisition Corp. II does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on businesses in the healthcare, industrials, consumer, media, technology, and technology services sector. The company was incorporated in 2020 and is based in New York, New York.

Thermo Fisher Scientific NYSE:TMO

$426.65 +7.95 (+1.90%)

Closing price 03:59 PM Eastern

Extended Trading

$424.10 -2.55 (-0.60%)

As of 07:56 PM Eastern

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time